Valipharma is a biopharmaceutical company focused on developing personalised medicines for the treatment of cancer.

Valipharma has been exploiting over the past few years its proprietary epigenomic technology to develop promising therapeutics. They may prove in clinical trials to combat cancer safely and more effectively than currently used chemotherapeutics.

Currently, ValiPharma has two lead drug candidates in late stage pre-clinical development for three indications.

Find out more